P13.02 Conventional MRI radiomics in the diagnosis of early- and pseudo-progression

BACKGROUND: After radiochemotherapy, 20% to 30% of patients with early worsening MRI experience pseudoprogression (Psp) which is not distinguishable from early progression (EP). We aimed to assess the diagnostic performance and survival predictive ability of radiomics in patients with suspected EP o...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Neuro Oncol
Main Authors: Bani Sadr, A, Eker, O F, Berner, L, Ameli, R, Hermier, M, Barritault, M, Meyronet, D, Guyotat, J, Jouanneau, E, Honnorat, J, Ducray, F, Berthezène, Y
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2019
Assuntos:
Poster Presentations
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6796042/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noz126.223
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados